Beyond Air, Inc. (XAIR) Reports In-Line Q1 EPS, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Beyond Air® Reports Financial Results for Second Quarter of Fiscal Year 2021 and Provides Business Update
November 11, 2020 4:10 PM ESTSubmitted a premarket approval (PMA) to the FDA for LungFit PH to treat persistent pulmonary hypertension of the newborn (PPHN)
Expect patient enrollment to begin next week for the acute viral pneumonia (including SARS-CoV-2) study; Patients will be treated with 150 ppm nitric oxide with LungFit PRO
LungFit GO nontuberculous mycobacteria (NTM) lung infection at-home pilot study expected to start in... More
